214 related articles for article (PubMed ID: 22369374)
1. Using NF-κB as a molecular target for theranostics in radiation oncology research.
Liu YC; Chiang IT; Hsu FT; Hwang JJ
Expert Rev Mol Diagn; 2012 Mar; 12(2):139-46. PubMed ID: 22369374
[TBL] [Abstract][Full Text] [Related]
2. Sorafenib sensitizes human colorectal carcinoma to radiation via suppression of NF-κB expression in vitro and in vivo.
Kuo YC; Lin WC; Chiang IT; Chang YF; Chen CW; Su SH; Chen CL; Hwang JJ
Biomed Pharmacother; 2012 Feb; 66(1):12-20. PubMed ID: 22265104
[TBL] [Abstract][Full Text] [Related]
3. Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck.
Allen CT; Ricker JL; Chen Z; Van Waes C
Head Neck; 2007 Oct; 29(10):959-71. PubMed ID: 17405170
[TBL] [Abstract][Full Text] [Related]
4. Nuclear transcription factor-kappaB as a target for cancer drug development.
Garg A; Aggarwal BB
Leukemia; 2002 Jun; 16(6):1053-68. PubMed ID: 12040437
[TBL] [Abstract][Full Text] [Related]
5. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
6. The role of nuclear factor kappaB in pancreatic cancer and the clinical applications of targeted therapy.
Holcomb B; Yip-Schneider M; Schmidt CM
Pancreas; 2008 Apr; 36(3):225-35. PubMed ID: 18362834
[TBL] [Abstract][Full Text] [Related]
7. The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy.
Wu JT; Kral JG
J Surg Res; 2005 Jan; 123(1):158-69. PubMed ID: 15652965
[TBL] [Abstract][Full Text] [Related]
8. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.
Gollob JA; Wilhelm S; Carter C; Kelley SL
Semin Oncol; 2006 Aug; 33(4):392-406. PubMed ID: 16890795
[TBL] [Abstract][Full Text] [Related]
9. NF-κB as a potential therapeutic target in myelodysplastic syndromes and acute myeloid leukemia.
Breccia M; Alimena G
Expert Opin Ther Targets; 2010 Nov; 14(11):1157-76. PubMed ID: 20858024
[TBL] [Abstract][Full Text] [Related]
10. Targeting NF-kappaB for colorectal cancer.
Sakamoto K; Maeda S
Expert Opin Ther Targets; 2010 Jun; 14(6):593-601. PubMed ID: 20367537
[TBL] [Abstract][Full Text] [Related]
11. Decrease in RelA phosphorylation by inhibiting protein kinase A induces cell death in NF-kappaB-expressing and drug-resistant tumor cells.
Manna SK; Gangadharan C
Mol Immunol; 2009 Apr; 46(7):1340-50. PubMed ID: 19128834
[TBL] [Abstract][Full Text] [Related]
12. Nuclear factor-kappaB activation: from bench to bedside.
Sethi G; Sung B; Aggarwal BB
Exp Biol Med (Maywood); 2008 Jan; 233(1):21-31. PubMed ID: 18156302
[TBL] [Abstract][Full Text] [Related]
13. Novel approaches to target NF-κB and other signaling pathways in cancer stem cells.
Ukaji T; Umezawa K
Adv Biol Regul; 2014 Sep; 56():108-15. PubMed ID: 25128192
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 inhibitor, nimesulide, improves radiation treatment against non-small cell lung cancer both in vitro and in vivo.
Grimes KR; Warren GW; Fang F; Xu Y; St Clair WH
Oncol Rep; 2006 Oct; 16(4):771-6. PubMed ID: 16969492
[TBL] [Abstract][Full Text] [Related]
15. Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy.
Li F; Sethi G
Biochim Biophys Acta; 2010 Apr; 1805(2):167-80. PubMed ID: 20079806
[TBL] [Abstract][Full Text] [Related]
16. NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates.
de Castro Barbosa ML; da Conceicao RA; Fraga AGM; Camarinha BD; de Carvalho Silva GC; Lima AGF; Cardoso EA; de Oliveira Freitas Lione V
Anticancer Agents Med Chem; 2017; 17(4):483-490. PubMed ID: 27481554
[TBL] [Abstract][Full Text] [Related]
17. Fungal metabolites modulating NF-kappaB activity: an approach to cancer therapy and chemoprevention (review).
Petrova RD; Reznick AZ; Wasser SP; Denchev CM; Nevo E; Mahajna J
Oncol Rep; 2008 Feb; 19(2):299-308. PubMed ID: 18202775
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway.
Ciucci A; Gianferretti P; Piva R; Guyot T; Snape TJ; Roberts SM; Santoro MG
Mol Pharmacol; 2006 Nov; 70(5):1812-21. PubMed ID: 16908599
[TBL] [Abstract][Full Text] [Related]
19. Targeting the NF-κB pathway in cancer therapy.
Erstad DJ; Cusack JC
Surg Oncol Clin N Am; 2013 Oct; 22(4):705-46. PubMed ID: 24012396
[TBL] [Abstract][Full Text] [Related]
20. Targeting NF-κB and HIF-1 pathways for the treatment of cancer: part I.
Wilczynski J; Duechler M; Czyz M
Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):289-99. PubMed ID: 21625848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
